Quanta BioDesign

Quanta BioDesign is a research and manufacturing company committed to the development of a full range of discrete polyethylene glycol (dPEG®) PEGylation reagents for applications in diagnostics, therapeutics, peptide synthesis, oligonucleotide synthesis, and nanotechnology.

Quanta BioDesign’s vision incorporates a dedicated commitment to producing the most useful compounds for your current and future applications and needs using synthetic and process technology that allows the most economic incorporation of these products into your application.


PEGS 2016

April 25 – 29, 2016
Seaport World Trade Center
Boston, MA
Booth # 213


TIDES 2016

May 9 – 12, 2016
Long Beach Convention Center
Long Beach, CA